Sales rise 5.09% to Rs 1561.73 crore
Net profit of Alembic Pharmaceuticals rose 11.70% to Rs 134.71 crore in the quarter ended June 2024 as against Rs 120.60 crore during the previous quarter ended June 2023. Sales rose 5.09% to Rs 1561.73 crore in the quarter ended June 2024 as against Rs 1486.15 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales1561.731486.15 5 OPM %15.1613.37 -PBDT226.07195.94 15 PBT157.03129.76 21 NP134.71120.60 12Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content